Is deferasirox implicated in multiple organ failure in a patient with homozygous β-thalassemia?
Τίτλος | Is deferasirox implicated in multiple organ failure in a patient with homozygous β-thalassemia? |
Publication Type | Journal Article |
Year of Publication | 2011 |
Authors | Vlachaki, E., Chatzinikolaou K., Bekiari E., Klonizakis F., & Tsapas A. |
Journal | Angiology |
Volume | 62 |
Issue | 4 |
Pagination | 346-8 |
Date Published | 2011 May |
ISSN | 1940-1574 |
Λέξεις κλειδιά | Adult, Benzoates, beta-Thalassemia, Chelation Therapy, Fatal Outcome, Humans, Iron Chelating Agents, Male, Multiple Organ Failure, Risk Factors, Triazoles |
Abstract | We herein report a case of a thalassemic-patient who was on deferasirox chelation therapy and admitted to the emergency department because of fever, diffuse abdominal pain and altered mental status. Despite the appropriate treatment he died two days later due to cardiac arrest. As we failed to recognize any etiology and the patients' relatives denied a post mortem examination due to religious reasons, we cannot provide any additional data. However, we are wondering whether this incident might be related to deferasirox. |
DOI | 10.1177/0003319710394160 |
Alternate Journal | Angiology |
PubMed ID | 21306999 |